Receptor Partners is a venture capital firm based in New York, New York.
The firm invests in the future of psychedelic medicine.
Receptor's portfolio includes Beckley Psytech, Psilera, Mind State Design, Brightminds, Tactogen, Delix, Freedom Bio, and Cybin.
Receptor was founded in 2021.
People
- Zack Sherman, General Partner
You last contacted this investor on .